90 related articles for article (PubMed ID: 25833414)
1. Costs in different states of prostate cancer.
Torvinen S; Färkkilä N; Roine RP; Sintonen H; Saarto T; Taari K
Acta Oncol; 2016; 55(1):30-7. PubMed ID: 25833414
[TBL] [Abstract][Full Text] [Related]
2. Costs of colorectal cancer in different states of the disease.
Färkkilä N; Torvinen S; Sintonen H; Saarto T; Järvinen H; Hänninen J; Taari K; Roine RP
Acta Oncol; 2015 Apr; 54(4):454-62. PubMed ID: 25519708
[TBL] [Abstract][Full Text] [Related]
3. Costs in Different States of Breast Cancer.
Roine E; Färkkilä N; Sintonen H; Taari K; Roine RP; Saarto T
Anticancer Res; 2019 Jan; 39(1):353-359. PubMed ID: 30591480
[TBL] [Abstract][Full Text] [Related]
4. The economic burden of prostate cancer - a Swedish prevalence-based register study.
Hao S; Östensson E; Eklund M; Grönberg H; Nordström T; Heintz E; Clements M
BMC Health Serv Res; 2020 May; 20(1):448. PubMed ID: 32434566
[TBL] [Abstract][Full Text] [Related]
5. Costs and quality of life of multiple sclerosis in Austria.
Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in prostate cancer.
Torvinen S; Färkkilä N; Sintonen H; Saarto T; Roine RP; Taari K
Acta Oncol; 2013 Aug; 52(6):1094-101. PubMed ID: 23368678
[TBL] [Abstract][Full Text] [Related]
7. Cost of illness of medically treated benign prostatic hyperplasia in Hungary.
Rencz F; Kovács Á; Brodszky V; Gulácsi L; Németh Z; Nagy GJ; Nagy J; Buzogány I; Böszörményi-Nagy G; Majoros A; Nyirády P
Int Urol Nephrol; 2015 Aug; 47(8):1241-9. PubMed ID: 26093585
[TBL] [Abstract][Full Text] [Related]
8. Costs and quality of life for patients with multiple sclerosis in Belgium.
Kobelt G
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
[TBL] [Abstract][Full Text] [Related]
9. Costs and quality of life of multiple sclerosis in Italy.
Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
[TBL] [Abstract][Full Text] [Related]
10. Costs and quality of life in multiple sclerosis in The Netherlands.
Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
[TBL] [Abstract][Full Text] [Related]
11. Costs and quality of life of multiple sclerosis in Spain.
Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
[TBL] [Abstract][Full Text] [Related]
12. Healthcare costs associated with prostate cancer: estimates from a population-based study.
Krahn MD; Zagorski B; Laporte A; Alibhai SM; Bremner KE; Tomlinson G; Warde P; Naglie G
BJU Int; 2010 Feb; 105(3):338-46. PubMed ID: 19594734
[TBL] [Abstract][Full Text] [Related]
13. The economic burden of prostate cancer, California, 1998.
Max W; Rice DP; Sung HY; Michel M; Breuer W; Zhang X
Cancer; 2002 Jun; 94(11):2906-13. PubMed ID: 12115378
[TBL] [Abstract][Full Text] [Related]
14. [Treatment costs of localized prostate cancer in Germany : Economic results from the HAROW observational study].
Reinhold T; Dornquast C; Börgermann C; Weißbach L
Urologe A; 2016 Dec; 55(12):1573-1585. PubMed ID: 27822603
[TBL] [Abstract][Full Text] [Related]
15. Costs and quality of life of multiple sclerosis in Germany.
Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337
[TBL] [Abstract][Full Text] [Related]
16. Estimating the Cost of Illness of Prostate Cancer in Iran.
Mojahedian MM; Toroski M; Keshavarz K; Aghili M; Zeyghami S; Nikfar S
Clin Ther; 2019 Jan; 41(1):50-58. PubMed ID: 30545740
[TBL] [Abstract][Full Text] [Related]
17. Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality-adjusted life-year analysis.
Sanyal C; Aprikian AG; Cury FL; Chevalier S; Dragomir A
Cancer; 2016 Apr; 122(7):1085-96. PubMed ID: 26828716
[TBL] [Abstract][Full Text] [Related]
18. Costs and quality of life of multiple sclerosis in Switzerland.
Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
[TBL] [Abstract][Full Text] [Related]
19. Breast and prostate cancer productivity costs: a comparison of the human capital approach and the friction cost approach.
Hanly P; Timmons A; Walsh PM; Sharp L
Value Health; 2012 May; 15(3):429-36. PubMed ID: 22583452
[TBL] [Abstract][Full Text] [Related]
20. The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings.
Wimo A; Reed CC; Dodel R; Belger M; Jones RW; Happich M; Argimon JM; Bruno G; Novick D; Vellas B; Haro JM
J Alzheimers Dis; 2013; 36(2):385-99. PubMed ID: 23629588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
